The massive sale by a 10% owner creates significant overhang and signals potential further distribution. Monitor for any subsequent Form 4 filings from SVF Pauling or other major holders. The stock may face selling pressure as the market digests this large block trade.
RLAY drugs
RLAY drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Aug 28 $18.77entry
- T+1 · 3mo ago −2.08%α −1.78% · $18.38
- T+5 · 2mo ago +1.44%α +1.33% · $19.04
- T+20 · 7w ago −5.75%α −6.01% · $17.69
- T+55 · todayOpen
- T+60 · in 6d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two insiders at Relay Therapeutics sold a combined $116.49M in shares over a 7-day window. The overwhelming majority ($116.4M) came from a single 10% owner, SVF Pauling (Cayman) Ltd, selling 6 million shares at $19.40. A smaller open-market sale of $90K by another insider occurred the next day. This cluster represents 2.7% of the company's $4.3B market cap, a highly material amount that signals a significant reduction in a major holder's position, likely for portfolio or liquidity reasons rather than a bearish view on the pipeline, but the sheer size warrants attention.
Key Financial Metrics
Key Facts
- SVF Pauling (Cayman) Ltd, a 10% owner, sold 6,000,000 shares for $116.4M on August 25, 2026.
- Rahmer Peter sold 4,508 shares for $90,295 on August 26, 2026.
- Total cluster value of $116.49M represents approximately 2.7% of RLAY's $4.3B market cap.
- The cluster is heavily dominated by a single 10% owner's sale, not a broad C-suite sell-off.
Financial Impact
Sale of $116.4M by a 10% owner, representing 2.7% of market cap
Risk Factors
- The 10% owner's sale may be for non-informational reasons (e.g., fund redemption, portfolio rebalancing), not a negative view on the company.
- The sale could create a temporary overhang that resolves quickly if the buyer is a long-term institutional holder.
- The company's strong pipeline and 95% analyst bullish consensus could offset selling pressure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RLAY-1787983797242 |
Track record
21 reports on RLAY
6 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +65.12% at T+60 after the May 19, 2026 report. 7 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $17.68 Now $17.27 −2.29% settles Feb 12
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $17.00 Now $17.27 +1.59% settles Feb 3
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $17.44 Now $17.27 −0.97% settles Feb 1
- Oct 7, 20265w ago 144 Neutral 2/10 Entry $17.41 Now $17.27 −0.80% settles Jan 5
- Oct 6, 20265w ago 144 Neutral 3/10 Entry $17.95 Now $17.27 −3.79% settles Jan 4
- Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $18.89 Now $17.27 −8.58% settles Dec 4
- Aug 28, 202611w ago Insider Cluster Bearish 6/10 Viewing Entry $18.77 Now $17.27 +7.99% settles Nov 23
- Aug 18, 202612w ago Insider Cluster Bearish 5/10 Entry $20.74 to $19.72 Now $17.27 +16.73% ▲ +4.92% +4.09% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers